Related Experiment Videos
Electroencephalogram in tardive dyskinesia
Clinical EEG (Electroencephalography)
|October 1, 1984
Summary
Electroencephalogram abnormalities in patients with affective disorder and schizophrenia are primarily drug-induced, not linked to tardive dyskinesia. This study found no specific electroencephalogram changes associated with tardive dyskinesia.
Area of Science:
- Neuroscience
- Psychiatry
- Clinical Neurophysiology
Background:
- Tardive dyskinesia (TD) is a movement disorder associated with antipsychotic medication.
- Electroencephalogram (EEG) abnormalities are common in patients with psychiatric disorders.
- The relationship between EEG findings and TD in affective disorder and schizophrenia is not well-established.
Purpose of the Study:
- To investigate if specific electroencephalogram (EEG) changes are associated with tardive dyskinesia (TD) in patients with affective disorder and schizophrenia.
- To determine the prevalence of EEG abnormalities in these patient groups.
- To differentiate between drug-induced EEG changes and those potentially related to TD.
Main Methods:
- Electroencephalogram (EEG) recordings were obtained from patients diagnosed with affective disorder or schizophrenia.
- Patients were categorized based on the presence or absence of tardive dyskinesia (TD).
- EEG data were analyzed to identify and compare abnormalities across different patient groups.
Main Results:
- No significant differences in electroencephalogram (EEG) abnormalities were observed between patients with and without tardive dyskinesia (TD).
- The majority of observed EEG abnormalities were attributed to medication effects.
- Specific EEG patterns were not found to be uniquely associated with tardive dyskinesia.
Conclusions:
- Tardive dyskinesia (TD) is not associated with distinct electroencephalogram (EEG) changes in patients with affective disorder and schizophrenia.
- Electroencephalogram (EEG) abnormalities in these populations are largely drug-induced.
- Further research may be needed to explore other potential biomarkers for TD.